Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative
This study is ongoing, but not recruiting participants.
Study NCT00841516   Information provided by Allergopharma GmbH & Co. KG

First Received on February 10, 2009.   Last Updated on January 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Allergic Rhinoconjunctivitis
Additional conditions recognized in this trial
Conjunctivitis
Conjunctivitis, Allergic
More general conditions related to this trial
Conjunctival Diseases
Eye Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Interventions listed in this trial
Placebo
rBet v1-FV
Sponsors listed in this trial
Allergopharma GmbH & Co. KG


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services